Literature DB >> 3308209

Transfer of maternal specific cell-mediated immunity to the fetus.

H F Pabst1, J C Godel, D W Spady, K Cho.   

Abstract

The extent of specific cell-mediated immunity was measured in 67 consecutive newborns and their mothers. The stimulation index of blast transformation of the infants' lymphocytes in the presence of purified protein derivative, Candida extract and streptokinase was greater than 2.0 in 54%, 18% and 23% respectively. This was seen only in infants whose mothers' index was also greater than 2.0 to the same antigen. Leucocyte inhibition factor generated from lymphocytes of four babies in the presence of purified protein derivative inhibited migration of indicator cells over 50%; their stimulation index with purified protein derivative was greater than 2.0. Newborns have cell mediated immunity to the same antigens as their mothers, and this wanes during the first few months of life.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3308209      PMCID: PMC1542680     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Immunologic response in vitro after thymechtomy in patients with myasthenia gravis.

Authors:  T Bowen; H F Pabst
Journal:  Can Med Assoc J       Date:  1976-10-09       Impact factor: 8.262

2.  Is maternal lymphocyte sensitisation passed to the child?

Authors:  E J Field; E A Caspary
Journal:  Lancet       Date:  1971-08-14       Impact factor: 79.321

3.  The possible induction and-or acquisition of cellular hypersensitivity associated with ingestion of colostrum.

Authors:  J A Mohr
Journal:  J Pediatr       Date:  1973-06       Impact factor: 4.406

4.  Successful treatment of candidiasis with transfer factor.

Authors:  H F Pabst; R Swanson
Journal:  Br Med J       Date:  1972-05-20

5.  Deletion of antigen-specific activity from leukocyte dialysates containing transfer factor by antigen-coated polystyrene.

Authors:  W Borkowsky; H S Lawrence
Journal:  J Immunol       Date:  1981-02       Impact factor: 5.422

6.  Transplacental passage of blood cells.

Authors:  J Schröder
Journal:  J Med Genet       Date:  1975-09       Impact factor: 6.318

7.  Tuberculin purified protein derivative-reactive T cells in cord blood lymphocytes.

Authors:  H Shiratsuchi; I Tsuyuguchi
Journal:  Infect Immun       Date:  1981-09       Impact factor: 3.441

8.  Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn.

Authors:  S S Ogra; D Weintraub; P L Ogra
Journal:  J Immunol       Date:  1977-07       Impact factor: 5.422

9.  Cell-mediated immune responsiveness to measles. Its occurrence as a result of naturally acquired or vaccine-induced infection and in infants of immune mothers.

Authors:  M R Gallagher; R Welliver; T Yamanaka; B Eisenberg; M Sun; P L Ogra
Journal:  Am J Dis Child       Date:  1981-01

10.  Immunologic and medical considerations in tuberculin-sensitized pregnant patients.

Authors:  H D Covelli; R T Wilson
Journal:  Am J Obstet Gynecol       Date:  1978-10-01       Impact factor: 8.661

View more
  3 in total

1.  In-utero infection with HIV-1 associated with suppressed lymphoproliferative responses at birth.

Authors:  B Lohman-Payne; T Sandifer; M OhAinle; C Crudder; J Lynch; M M Omenda; J Maroa; K Fowke; G C John-Stewart; C Farquhar
Journal:  Clin Exp Immunol       Date:  2014-10       Impact factor: 4.330

2.  BCG vaccination of full-term infants with chronic intrauterine malnutrition: influence of immunization age on development of post-vaccination, delayed tuberculin hypersensitivity.

Authors:  M M Mussi-Pinhata; A L Goncalves; N T Foss
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

Review 3.  A practical guide to large-scale docking.

Authors:  Brian J Bender; Stefan Gahbauer; Andreas Luttens; Jiankun Lyu; Chase M Webb; Reed M Stein; Elissa A Fink; Trent E Balius; Jens Carlsson; John J Irwin; Brian K Shoichet
Journal:  Nat Protoc       Date:  2021-09-24       Impact factor: 17.021

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.